
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) and microbiome data reveal kidney markers of diabetic disease.
Click the title above to open The Column June 2019 Europe & Asia issue, Volume 15, Number 6, in an interactive PDF format.
over 7 years ago
Vol 15 No 6 The Column June 2019 North American PDFover 7 years ago
A Design for Life Sciencesover 7 years ago
Need a New Instrument to Innovate?over 7 years ago
Refining Nucleic Acid Characterization Using HILIC–MSover 7 years ago
The LCGC Blog: Forensic Drug Analysis: GC–MS versus LC–MS





